Advertisement
ASRS recognizes Rishi P. Singh, MD, for work in diabetic eye disease
Cleveland Clinic Cole Eye Institute’s Rishi P. Singh, MD, has been selected to deliver the prestigious American Society of Retina Specialists (ASRS) President’s Award Lecture at the society’s annual meeting in Vancouver, British Columbia, on Sunday, July 22.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The award is given in recognition of an outstanding paper published during the past year and other accomplishments that signal potential for future impactful contributions to the field. Dr. Singh, Associate Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, will speak on “Advancing Insights into Diabetic Eye Disease,” summarizing his 12-plus peer-reviewed research papers published on this topic in 2017 alone.
Dr. Singh’s clinical interests include both medical and surgical treatments of retinal diseases and disorders. He has extensive experience in the management of age-related macular degeneration (AMD), diabetic retinopathy, and surgical retinal conditions such as retinal detachments.
“Dr. Singh is a multitalented, multifaceted ophthalmologist, who we are indeed fortunate to have on staff,” says Daniel F. Martin, MD, Chair, Cole Eye Institute, and Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology. “Dr. Singh’s interests and talents represent the best of academic medicine – from performing vital clinical research to serving as journal editor, from leading our electronic medical record effort to being a prolific author, and most important, being a compassionate clinician. I along with our entire staff congratulate Dr. Rishi on his latest well-deserved honor, the ASRS President’s Award.”
Dr. Singh’s primary research interest is clinical investigation that harnesses data from the electronic record to help elucidate mechanisms of disease and better inform treatment decisions to help improve patient outcomes.
Advertisement
As Medical Director of the Clinical Systems Office, Dr. Singh oversaw successful implementation of the electronic medical record for the institute. He is now focused on big data analyses, machine learning, lean process improvement, and decision support modules for clinical practice.
Dr. Singh has authored more than 110 peer-reviewed publications, books and book chapters, and he serves as principal investigator for numerous national clinical trials advancing the treatment of retinal disease. He is a frequent guest speaker at national and international meetings and continuing medical education seminars.
He is President of the Retina World Congress and is on the board of the American Society of Retina Specialists.
Dr. Singh is associate editor of Ophthalmic Surgery, Lasers and Imaging Retina Journal (OSLI-Retina) and one of the editors of the American Journal of Ophthalmic Clinical Trials. He maintains a strong relationship with drug development and commercial entities by serving on scientific advisory boards. Dr. Singh has received the Alpha Omega Alpha Research Award, Cleveland Clinic Early Career Innovator Award, and the American Society of Retina Specialists Senior Honor Award.
Dr. Singh, a member of Cleveland Clinic’s Board of Governors, completed medical school at Boston University followed by residency in ophthalmology at Massachusetts Eye and Ear Infirmary, Harvard University. He completed a fellowship in vitreoretinal surgery and diseases at Cleveland Clinic.
Dr. Singh’s lecture will be published by the Journal of Vitreoretinal Diseases (JVRD).
Advertisement
Advertisement
Cole Eye Institute imaging specialists are equal parts technician, artist and diagnostician
Innovative work earns ASRS and Macula Society awards for Justis P. Ehlers, MD
Speakers and topics for Booth 3254
Former internship year now includes specialization in eye care
The art of refractive cataract surgery
Is disorganization of retinal inner layers (DRIL) a useful prognostic indicator?
Major address at American Academy of Ophthalmology Meeting
How ophthalmologists should interpret and implement this notification